Familial Hypercholesterolemia - Heterozygous
8 clinical trials · Condition
◉ Watch Familial Hypercholesterolemia - Heterozygous
| Record | Firm | Date |
|---|---|---|
| Advancing Cardiac Care Unit-based Rapid Assessment and Treatment of hypErcholesterolemia (NCT05218005) | University of British Columbia | 2022-01-01 |
| Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Heterozygous Familial Hypercholesterolemia (NCT04652726) | Novartis Pharmaceuticals | 2021-01-27 |
| Genetic Testing and Motivational Counseling for FH (NCT04656028) | National Medical Research Center for Therapy and Preventive Medicine | 2020-06-15 |
| Study of Coronary Calcification in Subjects With Autosomal Dominant Familial Hypercholesterolemia Heterozygous (NCT03501875) | Assistance Publique - Hôpitaux de Paris | 2018-05-15 |
| MYOCARDIAL SILENT INFARCTIONS AND FIBROSIS IN FAMILIAL HYPERCHOLESTEROLEMIA (CHOLCOEUR) (NCT02517944) | Institute of Cardiometabolism and Nutrition, France | 2014-11-01 |
| Early Detection of Familial Hypercholesterolemia in Children (NCT04370899) | Institut Investigacio Sanitaria Pere Virgili | 2013-03-14 |
Track Familial Hypercholesterolemia - Heterozygous automatically
Every clearance here is in the API, with alerts when new ones post.